Bioventus (BVS) Stock Price

$6.8 0%

Sign up
to add to portfolio

AI Score

Sell

  • Alternative

    4

  • Fundamental

    3

  • Technical

    3

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Bioventus, AI stock picks, stock alerts and much more.

Sign up

BVS AI Stock Analysis

AI stock analysis for BVS is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Bioventus (BVS) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Bioventus (BVS) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Bioventus (BVS), currently trading at $6.8, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About BVS

LSE

Similar Stocks

ALGN Align Technology
ALGN		 $180.9
5.1%
6
IRTC iRhythm Technologies
IRTC		 $137
0.6%
7
DXCM Dexcom
DXCM		 $85.34
2.4%
5
BRKR Bruker
BRKR		 $40.51
0.6%
6
TMCI Treace Medical Concepts
TMCI		 $7.54
4.7%
4

News

Bioventus Inc. (BVS) Q1 2025 Earnings Call Transcript

Bioventus Inc. (BVS) Q1 2025 Earnings Call Transcript
May 6, 2025. seekingalpha.com
Bioventus Reports First Quarter Financial Results

Bioventus Reports First Quarter Financial Results
May 6, 2025. globenewswire.com
Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025

Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025
April 28, 2025. globenewswire.com
4 Healthcare Stocks to Buy as the Sector Faces Government Heat

4 Healthcare Stocks to Buy as the Sector Faces Government Heat
April 17, 2025. zacks.com

BVS Alternative Data

Web Traffic

Bioventus receives an estimated 12096 monthly visitors to bioventus.com.

  • Web Traffic

    12096

  • Change from Previous Month

    31.9%

  • 3 Month Change

    19.3%

  • YoY Change

    19.3%

Twitter Followers

Bioventus has 1,854 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.1% over the last month.

  • Twitter Followers

    1854

  • Daily Change

    0.1%

  • 1 Month Change

    0.1%

  • 3 Month Change

    0.5%

  • YoY Change

    0.5%

Facebook Engagement

Bioventus has engaged 0 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    100%

  • YoY Change

    100%

Instagram Followers

Bioventus has 695 Instagram Followers on its main Instagram account, up by 0.9% over the last month.

  • Instagram Followers

    695

  • Daily Change

    0%

  • 1 Month Change

    0.9%

  • 3 Month Change

    5%

  • YoY Change

    5%

Youtube Subscribers

Bioventus has 25,200 subscribers on its main Youtube channel, up by 0.4% over the last month.

  • Youtube Subscribers

    25200

  • Daily Change

    0%

  • 1 Month Change

    0.4%

  • 3 Month Change

    1.2%

  • YoY Change

    1.2%

LinkedIn Followers

41,221 are following Bioventus on LinkedIn, up by 1.1% over the last month.

  • LinkedIn Followers

    41221

  • Daily Change

    0%

  • 1 Month Change

    1.1%

  • 3 Month Change

    3.8%

Job Postings

Bioventus has an estimated 25 open job postings, which is down -39% over the last month.

  • Job Postings

    25

  • Daily Change

    7.4%

  • 1 Month Change

    39%

  • 3 Month Change

    60.3%

  • YoY Change

    60.3%

LinkedIn Employees

According to LinkedIn, Bioventus has 1,107 employees, up by 0.6% over the last month.

  • LinkedIn Employees

    1107

  • Daily Change

    0%

  • 1 Month Change

    0.6%

  • 3 Month Change

    0.5%

  • YoY Change

    0.5%

Reddit Mentions

Bioventus has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

News Mentions

Bioventus was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Business Outlook

According to employee reviews, the business outlook among employees at Bioventus is 49 out of 100 (neutral).

  • Business Outlook

    49

  • Change from Previous Month

    7.5%

  • 3 Month Change

    0%

  • YoY Change

    0%

BVS Financials

BVS Key Metrics

  • Total Revenue

    $153.6M

  • Net Income

    -$156K

  • Earnings per Share

    -$0.0024

  • Free cash flow

    $18.7M

  • EBITDA

    $11M

  • EBITDA Ratio

    0.0715755

  • Total Assets

    $728M

BVS 2-year Revenue & Income
BVS 2-year Free Cash Flow

BVS Technicals

BVS SMA
BVS RSI

FAQ

What's the current price of Bioventus (BVS) Stock?
The price of an Bioventus (BVS) share is $6.8.

What's the market cap of Bioventus?
The current market cap of Bioventus is 450.4M.

Should I buy or sell BVS?
Bioventus exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.

Is Bioventus a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Bioventus stock. There are several bearish signals and market challenges that could negatively impact Bioventus' future performance, suggesting that caution should be exercised before making any investment decisions.

Is now a good time to buy Bioventus (BVS) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Bioventus stock right now, as the outlook appears bearish.

What are some stocks similar to Bioventus (BVS) that investors often compare it to?
Bioventus (BVS) is often compared to similar stocks such as Align Technology, iRhythm Technologies, Dexcom, Bruker and Treace Medical Concepts.

What is the forecast for Bioventus' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Bioventus' stock price to be around $6.37 in 2026. Starting from the current price of $6.8, this represents a 6.3% change in price, indicating a bearish outlook for the stock.

How to buy Bioventus (BVS) Stock?
Bioventus stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Bioventus shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.